Tower Research Capital (TRC)’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.72K | Buy |
+6,189
| New | +$3.72K | ﹤0.01% | 4443 |
|
|
2025
Q1 | – | Sell |
-760
| Closed | -$396 | – | 5685 |
|
|
2024
Q4 | $396 | Buy |
+760
| New | +$396 | ﹤0.01% | 5288 |
|
|
2024
Q3 | – | Sell |
-2,754
| Closed | -$8.26K | – | 5935 |
|
|
2024
Q2 | $8.26K | Sell |
2,754
-7,002
| -72% | -$21K | ﹤0.01% | 4372 |
|
|
2024
Q1 | $45.4K | Buy |
9,756
+7,307
| +298% | +$34K | ﹤0.01% | 2350 |
|
|
2023
Q4 | $10.1K | Buy |
2,449
+739
| +43% | +$3.06K | ﹤0.01% | 4288 |
|
|
2023
Q3 | $5.13K | Sell |
1,710
-3,107
| -65% | -$9.32K | ﹤0.01% | 4756 |
|
|
2023
Q2 | $11.9K | Buy |
4,817
+198
| +4% | +$487 | ﹤0.01% | 3900 |
|
|
2023
Q1 | $10K | Sell |
4,619
-19,422
| -81% | -$42K | ﹤0.01% | 4400 |
|
|
2022
Q4 | $84K | Buy |
24,041
+23,189
| +2,722% | +$81K | ﹤0.01% | 1968 |
|
|
2022
Q3 | $32K | Sell |
852
-617
| -42% | -$23.2K | ﹤0.01% | 3556 |
|
|
2022
Q2 | $28K | Buy |
1,469
+1,261
| +606% | +$24K | ﹤0.01% | 3453 |
|
|
2022
Q1 | $6K | Sell |
208
-1,019
| -83% | -$29.4K | ﹤0.01% | 4917 |
|
|
2021
Q4 | $28K | Buy |
1,227
+546
| +80% | +$12.5K | ﹤0.01% | 3310 |
|
|
2021
Q3 | $18K | Sell |
681
-360
| -35% | -$9.52K | ﹤0.01% | 3834 |
|
|
2021
Q2 | $33K | Sell |
1,041
-757
| -42% | -$24K | ﹤0.01% | 3397 |
|
|
2021
Q1 | $63K | Buy |
1,798
+620
| +53% | +$21.7K | ﹤0.01% | 2933 |
|
|
2020
Q4 | $37K | Sell |
1,178
-11,104
| -90% | -$349K | ﹤0.01% | 3397 |
|
|
2020
Q3 | $462K | Buy |
12,282
+11,381
| +1,263% | +$428K | 0.01% | 1769 |
|
|
2020
Q2 | $40K | Buy |
+901
| New | +$40K | ﹤0.01% | 3235 |
|
|
2020
Q1 | – | Sell |
-2,143
| Closed | -$84K | – | 3763 |
|
|
2019
Q4 | $84K | Buy |
+2,143
| New | +$84K | 0.01% | 1043 |
|